AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

The Effect of phoSPHocreatine on mEdical Emergency Team (Met) tREated Patients

RecruitingPhase 3Ages 18 Years - anyAllUniversità Vita-Salute San Raffaele
💬

In plain words

What the trial is, and whether it could suit you

Unexpected deaths and unplanned intensive care unit (ICU) admissions are common during hospital stay and are often preceded by warning abnormalities in patients' vital signs. These abnormalities trigger Medical Emergency Team (MET) activation and up to 15% of patients visited by the MET is admitted to the ICU with an overall hospital stay after the MET intervention of approximately 2 weeks. Phosphocreatine (PCr) is a natural energy-buffering molecule associated with signals of mortality reduction in patients with acute cardiac conditions (according to meta-analytic finding from our group) and with encouraging beneficial effects on other acute organ failures (e.g. brain). The investigators designed a multi-center, randomized, placebo-controlled trial to confirm the promising beneficial effects of PCr in hospitalized patients. The investigators expects a reduction in hospital stay (measure

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: 1. Admitted in hospital (but outside ICU) 2. Age\>=18 years 3. Written informed consent 4. Serum creatinine \<=2 mg/dl 5. Patient with impending or underlying cardiac failure or cardiac arrest, irrespectively of the primitive organ failure, and the Medical Emergency Team (MET) is called upon at least one of the following: 1. Threatened airways; 2. Respiratory arrest; 3. Respiratory rate \<5 or \>36 breaths per min; 4. Pulse rate \<40 or \>140 beats per min; 5. Systolic blood pressure \< 90 mm Hg; 6. Sudden fall in level of consciousness; 7. Fall in Glasgow coma scale of \> 2 points. Exclusion Criteria: 1. Age \< 18 years; 2. Ongoing cardiac massage; 3. Current hospital admission from a care nursing facility; 4. Planned discharge to a care nursing facility; 5. Reasons for withdrawal of life-sustaining therapy; 6. History of kidney transplantation; 7. Solitary kidney (by any reason); 8. Serum Creatinine \> 2 mg/dl; 9. Immediate need for ICU admission; 10. Known allergy to PCr; 11. Pregnancy; 12. Previous enrollment and randomization into this trial; 13. Administration of PCr in the previous 30 day.
💊

What it tests

  • Phosphocreatine
  • Placebo
📍

Where

1 site
IRCCS San Raffaele Scientific Institute
Milan, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy